Pages that link to "Q35462240"

The following pages link to Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. (Q35462240):

Displaying 48 items.

• The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes (Q28087370) (← links)
• Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma (Q35936010) (← links)
• Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy (Q36326385) (← links)
• c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report (Q36741396) (← links)
• The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinosta (Q37477372) (← links)
• Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity (Q37705851) (← links)
• Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis (Q37711931) (← links)
• Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib (Q38627885) (← links)
• Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations. (Q38662451) (← links)
• Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group. (Q39162064) (← links)
• Expression of mesothelin in thymic carcinoma and its potential therapeutic significance (Q39235922) (← links)
• Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma (Q39239578) (← links)
• A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma. (Q39666412) (← links)
• Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors. (Q40096396) (← links)
• New findings on thymic epithelial tumors: Something is changing. (Q40430354) (← links)
• Rare frequency of gene variation and survival analysis in thymic epithelial tumors (Q41518202) (← links)
• Rare Case of Spinal Cord Compression as Initial Presentation of Thymic Carcinoma (Q45234027) (← links)
• Novel Agents in the Treatment of Thymic Malignancies. (Q48696917) (← links)
• Focal adhesion kinase is overexpressed in thymic epithelial tumors and may serve as an independent prognostic biomarker (Q49497914) (← links)
• Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features (Q49643762) (← links)
• The Integrated Genomic Landscape of Thymic Epithelial Tumors (Q50040409) (← links)
• Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study (Q50066887) (← links)
• Immune checkpoint inhibitors: the next step for thymic carcinomas. (Q50207707) (← links)
• Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells (Q50549009) (← links)
• Expression patterns, prognostic value, and intratumoral heterogeneity of PD-L1 and PD-1 in thymoma and thymic carcinoma. (Q52558663) (← links)
• [Thymomas]. (Q52955529) (← links)
• Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma. (Q54119194) (← links)
• Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib (Q57652304) (← links)
• The genomic and epigenomic landscape in thymic carcinoma (Q57700809) (← links)
• Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma (Q58572140) (← links)
• Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations (Q59793953) (← links)
• Impact of PD-L1, transforming growth factor-β expression and tumor-infiltrating CD8 T cells on clinical outcome of patients with advanced thymic epithelial tumors. (Q64946696) (← links)
• Sunitinib in thymic carcinoma: enigmas still unresolved (Q86542022) (← links)
• [Thymic carcinomas] (Q88154869) (← links)
• A mutational profile in multiple thymic squamous cell carcinoma (Q89639967) (← links)
• [Treatment of Recurrent Thymoma] (Q89894938) (← links)
• Deciphering the biology of thymic epithelial tumors (Q90682663) (← links)
• Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk? (Q90682666) (← links)
• Actualités et perspectives concernant l’immunothérapie en oncologie thoracique (Q90811886) (← links)
• WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity (Q91870565) (← links)
• Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014 (Q91911738) (← links)
• Deciphering tissue-based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors (Q92845358) (← links)
• S-1 salvage chemotherapy for stage IV thymic carcinoma: a study of 44 cases (Q92968360) (← links)
• Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas (Q95262488) (← links)
• Lenvatinib for thymic carcinomas (Q96165761) (← links)
• Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial (Q96165776) (← links)
• Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma (Q97681340) (← links)
• Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma (Q99408618) (← links)